Bone Biologics Corp (BBLG)

Finanzdaten der Bone Biologics Corp-Aktie (BBLG)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	17.54%0.67	0.81	0.81	0.73	0.72
Research and Development	21.43%0.24	0.31	0.14	0.26	0.19
Operating Income/Loss	17.54%-0.67	-0.81	-0.81	-0.73	-0.72
Nonoperating Income/Loss	41.52%0.05	0.03	0.04	0.05	0.05
	20.17%-0.62	-0.77	-0.80	-0.70	-0.67
Attributable To Parent	20.17%-0.62	-0.77	-0.77	-0.68	-0.67
Basic Average Shares	108.00%3.74	1.80	1.80	0.21	1.80
Diluted Average Shares	108.00%3.74	1.80	1.80	0.21	1.80
Basic Earnings Per Share	60.47%-0.17	-0.43	-0.43	-0.14	-0.37
Diluted Earnings Per Share	60.47%-0.17	-0.43	-0.43	-0.14	-0.37